☰

Troy D. Querec, Ph.D. - Publications

Affiliations: 
2007 Emory University, Atlanta, GA 
Area:
Virology Biology, Bioinformatics Biology
Tree Info Grants Similar researchers PubMed Report error

31 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Thapa HR, Unger ER, Querec TD. A human papillomavirus whole genome plasmid repository: A resource for HPV DNA quality control reagents. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 166: 105548. PMID 37499306 DOI: 10.1016/j.jcv.2023.105548  0.307
2023 Thapa HR, Unger ER, Querec TD. Evaluation of the Novaplex II HPV28 Detection Assay for HPV Typing in Formalin-Fixed Paraffin-Embedded Tissues. The Journal of Molecular Diagnostics : Jmd. PMID 36693473 DOI: 10.1016/j.jmoldx.2022.12.006  0.385
2022 Gargano JW, McClung N, Lewis RM, Park IU, Whitney E, Castilho JL, Pemmaraju M, Niccolai LM, Brackney M, Debess E, Ehlers S, Bennett NM, Scahill M, Cleveland AA, Querec TD, et al. HPV type-specific trends in cervical precancers in the United States, 2008-2016. International Journal of Cancer. PMID 35904861 DOI: 10.1002/ijc.34231  0.414
2022 Rosenblum HG, Lewis RM, Gargano JW, Querec TD, Unger ER, Markowitz LE. Human Papillomavirus Vaccine Impact and Effectiveness Through 12 Years After Vaccine Introduction in the United States, 2003 to 2018. Annals of Internal Medicine. PMID 35576590 DOI: 10.7326/M21-3798  0.597
2022 Lewis RM, Naleway AL, Klein NP, Crane B, Hsiao A, Aukes L, Timbol J, Querec TD, Steinau M, Weinmann S, Unger ER, Markowitz LE. Changes in Cervical Cytology Results and Human Papillomavirus Types Among Persons Screened for Cervical Cancer, 2007 and 2015-2017. Journal of Lower Genital Tract Disease. 26: 135-139. PMID 35316258 DOI: 10.1097/LGT.0000000000000659  0.382
2022 McClung N, Mathoma A, Gargano JW, Nyepetsi NG, Querec TD, Onyekwuluje J, Mine M, Morroni C, Luckett R, Markowitz LE, Ramogola-Masire D. HPV prevalence among young adult women living with and without HIV in Botswana for future HPV vaccine impact monitoring. Bmc Infectious Diseases. 22: 176. PMID 35193517 DOI: 10.1186/s12879-022-07130-x  0.431
2021 Winer RL, Lin J, Querec TD, Unger ER, Stern JE, Rudd JM, Golden MR, Swanson F, Markowitz LE, Meites E. Effectiveness Of Human Papillomavirus (HPV) Vaccination Against Penile Hpv Infection In Men Who Have Sex With Men And Transgender Women. The Journal of Infectious Diseases. PMID 34320185 DOI: 10.1093/infdis/jiab390  0.502
2021 Mix JM, Saraiya M, Thompson TD, Querec TD, Greek A, Tucker TC, Peters ES, Lynch CF, Hernandez BY, Copeland G, Goodman MT, Unger ER. Prevalence of human papillomavirus genotypes in high-grade cervical precancer and invasive cervical cancer from cancer registries before and after vaccine introduction in the United States. Cancer. PMID 34289090 DOI: 10.1002/cncr.33582  0.381
2021 Vahle K, Gargano JW, Lewis RM, Querec TD, Unger ER, Bednarczyk RA, Markowitz LE. Prevalence of human papillomavirus among females older than recommended age for vaccination by birth cohort, United States 2003‒2016. The Journal of Infectious Diseases. PMID 34161559 DOI: 10.1093/infdis/jiab334  0.397
2021 Lewis RM, Gargano JW, Unger ER, Querec TD, Markowitz LE. Genital human papillomavirus prevalence over the lifespan among females and males in a national cross-sectional survey, United States, 2013-2016. Sexually Transmitted Diseases. PMID 34009919 DOI: 10.1097/OLQ.0000000000001447  0.433
2021 Rosenblum HG, Lewis RM, Gargano JW, Querec TD, Unger ER, Markowitz LE. Declines in Prevalence of Human Papillomavirus Vaccine-Type Infection Among Females after Introduction of Vaccine - United States, 2003-2018. Mmwr. Morbidity and Mortality Weekly Report. 70: 415-420. PMID 33764964 DOI: 10.15585/mmwr.mm7012a2  0.57
2020 Meites E, Winer RL, Newcomb ME, Gorbach PM, Querec TD, Rudd J, Collins T, Lin J, Moore J, Remble T, Swanson F, Franz J, Bolan RK, Golden MR, Mustanski B, et al. Vaccine effectiveness on DNA prevalence of human papillomavirus infection in anal and oral specimens from men who have sex with men- United States, 2016-2018. The Journal of Infectious Diseases. PMID 32504091 DOI: 10.1093/Infdis/Jiaa306  0.518
2020 Tang YW, Lozano L, Chen X, Querec TD, Katabi N, Moreno-Docón A, Wang H, Fix D, De Brot L, McMillen TA, Yoon JY, Torroba A, Wang Y, Unger ER, Park KJ. An Isothermal, Multiplex Amplification Assay for Detection and Genotyping of Human Papillomaviruses in Formalin-Fixed, Paraffin-Embedded Tissues. The Journal of Molecular Diagnostics : Jmd. PMID 31978559 DOI: 10.1016/J.Jmoldx.2019.12.004  0.373
2019 Markowitz LE, Naleway AL, Klein NP, Lewis RM, Crane B, Querec TD, Hsiao A, Aukes L, Timbol J, Weinmann S, Liu G, Steinau M, Unger ER. Human Papillomavirus Vaccine Effectiveness Against HPV Infection: Evaluation of One, Two, and Three Doses. The Journal of Infectious Diseases. PMID 31784749 DOI: 10.1093/Infdis/Jiz555  0.56
2019 Johnson Jones ML, Gargano JW, Powell M, Park IU, Niccolai LM, Bennett NM, Griffin MR, Querec T, Unger ER, Markowitz LE. Effectiveness of 1, 2, AND 3 Human Papillomavirus Vaccine doses against HPV-16/18 positive High-grade Cervical Lesions. American Journal of Epidemiology. PMID 31680146 DOI: 10.1093/Aje/Kwz253  0.595
2019 Saadeh K, Park I, Gargano JW, Whitney E, Querec TD, Hurley L, Silverberg M. Prevalence of human papillomavirus (HPV)-vaccine types by race/ethnicity and sociodemographic factors in women with high-grade cervical intraepithelial neoplasia (CIN2/3/AIS), Alameda County, California, United States. Vaccine. PMID 31611099 DOI: 10.1016/J.Vaccine.2019.09.103  0.521
2019 McClung NM, Lewis RM, Gargano JW, Querec T, Unger ER, Markowitz LE. Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey. The Journal of Adolescent Health : Official Publication of the Society For Adolescent Medicine. PMID 31515134 DOI: 10.1016/J.Jadohealth.2019.07.003  0.636
2019 Markowitz LE, Naleway AL, Lewis RM, Crane B, Querec TD, Weinmann S, Steinau M, Unger ER. Declines in HPV vaccine type prevalence in women screened for cervical cancer in the United States: Evidence of direct and herd effects of vaccination. Vaccine. PMID 31160099 DOI: 10.1016/J.Vaccine.2019.04.099  0.657
2019 McClung NM, Gargano JW, Park IU, Whitney E, Abdullah N, Ehlers S, Bennett NM, Scahill M, Niccolai LM, Brackney M, Griffin MR, Pemmaraju M, Querec TD, Cleveland AA, Unger ER, et al. Estimated Number of Cases of High-Grade Cervical Lesions Diagnosed Among Women - United States, 2008 and 2016. Mmwr. Morbidity and Mortality Weekly Report. 68: 337-343. PMID 30998672 DOI: 10.15585/Mmwr.Mm6815A1  0.506
2019 Cleveland AA, Gargano JW, Park IU, Griffin MR, Niccolai LM, Powell M, Bennett NM, Saadeh K, Pemmaraju M, Higgins K, Ehlers S, Scahill M, Johnson Jones ML, Querec T, Markowitz LE, et al. Cervical Adenocarcinoma in Situ: Human Papillomavirus Types and Incidence Trends in Five States, 2008-2015. International Journal of Cancer. PMID 30980692 DOI: 10.1002/Ijc.32340  0.529
2019 McClung NM, Gargano JW, Bennett NM, Niccolai LM, Abdullah N, Griffin MR, Park IU, Cleveland AA, Querec TD, Unger ER, Markowitz LE. Trends in Human Papillomavirus Vaccine Types 16 and 18 in Cervical Precancers, 2008-2014. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30792242 DOI: 10.1158/1055-9965.Epi-18-0885  0.562
2019 Mix JM, Unger E, Querec T, Thompson T, Greek A, Tucker T, Lynch C, Peters E, Saraiya M. Abstract 4199: HPV prevalence of cervical cancer in the United States 2014-2015 Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-4199  0.342
2016 Lee EK, Nakaya HI, Yuan F, Querec TD, Burel G, Pietz FH, Benecke BA, Pulendran B. Machine Learning for Predicting Vaccine Immunogenicity Interfaces. 46: 368-390. DOI: 10.1287/Inte.2016.0862  0.702
2015 Panicker G, Rajbhandari I, Gurbaxani BM, Querec TD, Unger ER. Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types. Journal of Immunological Methods. 417: 107-14. PMID 25554636 DOI: 10.1016/J.Jim.2014.12.013  0.523
2013 Querec TD, Gurbaxani BM, Unger ER. Randomization modeling to ascertain clustering patterns of human papillomavirus types detected in cervicovaginal samples in the United States. Plos One. 8: e82761. PMID 24367553 DOI: 10.1371/Journal.Pone.0082761  0.462
2013 Edupuganti S, Eidex RB, Keyserling H, Akondy RS, Lanciotti R, Orenstein W, del Rio C, Pan Y, Querec T, Lipman H, Barrett A, Ahmed R, Teuwen D, Cetron M, Mulligan MJ, et al. A randomized, double-blind, controlled trial of the 17D yellow fever virus vaccine given in combination with immune globulin or placebo: comparative viremia and immunogenicity. The American Journal of Tropical Medicine and Hygiene. 88: 172-7. PMID 23208880 DOI: 10.4269/Ajtmh.2012.12-0179  0.646
2009 Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, Pirani A, Gernert K, Deng J, Marzolf B, Kennedy K, Wu H, Bennouna S, Oluoch H, Miller J, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nature Immunology. 10: 116-25. PMID 19029902 DOI: 10.1038/Ni.1688  0.691
2008 Pulendran B, Miller J, Querec TD, Akondy R, Moseley N, Laur O, Glidewell J, Monson N, Zhu T, Zhu H, Staprans S, Lee D, Brinton MA, Perelygin AA, Vellozzi C, et al. Case of yellow fever vaccine--associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. The Journal of Infectious Diseases. 198: 500-7. PMID 18598196 DOI: 10.1086/590187  0.686
2007 Belsher JL, Gay P, Brinton M, DellaValla J, Ridenour R, Lanciotti R, Perelygin A, Zaki S, Paddock C, Querec T, Zhu T, Pulendran B, Eidex RB, Hayes E. Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease. Vaccine. 25: 8480-5. PMID 18023511 DOI: 10.1016/J.Vaccine.2007.08.061  0.693
2007 Querec TD, Pulendran B. Understanding the role of innate immunity in the mechanism of action of the live attenuated Yellow Fever Vaccine 17D. Advances in Experimental Medicine and Biology. 590: 43-53. PMID 17191376 DOI: 10.1007/978-0-387-34814-8_3  0.67
2006 Querec T, Bennouna S, Alkan S, Laouar Y, Gorden K, Flavell R, Akira S, Ahmed R, Pulendran B. Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. The Journal of Experimental Medicine. 203: 413-24. PMID 16461338 DOI: 10.1084/Jem.20051720  0.61
Show low-probability matches.